Rob W. van der Pluijm

Author

Mahidol Oxford Tropical Medicine Research Unit ORCID

Also Known As

Ho Dang Trung, N, Kamija Phiri, R W van der Pluijm, R. W. van der Pluijm, R.W. van der Pluijm, Rob W Van Der Pluijm, Rob W Van der Pluijm, Rob W van der Pluijm, Rob W. van der Pluijm, William Yavo

Publications

Citations

H-Index

Concepts

All Affiliations

Mahidol Oxford Tropical Medicine Research Unit Mahidol University University of Oxford Cambodia National Malaria Center The Royal College Of Anesthesiologists Of Thailand

About

Rob W. van der Pluijm is an author at Mahidol Oxford Tropical Medicine Research Unit specializing in parasitology, medicine, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	60
2	Medical Laboratory Science	1	1	60
3	Pharmacology	1	1	60
4	Pharmacokinetics	1	1	60
5	Toxicology	1	1	60

Rob W. van der Pluijm

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong subregion: a molecular epidemiology observational study Mallika Imwong, Kanokon Suwannasin, Chanon Kunasol, The Lancet Infectious Diseases	2017	509
Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study Rob W. van der Pluijm, Mallika Imwong, Nguyễn Hoàng Châu, The Lancet Infectious Diseases	2019	398
Evolution and expansion of multidrug-resistant malaria in southeast Asia: a genomic epidemiology study William L. Hamilton, Roberto Amato, Rob W. van der Pluijm, The Lancet Infectious Diseases	2019	334
Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial Rob W. van der Pluijm, Rupam Tripura, Richard M. Hoglund, The Lancet	2020	270
Molecular epidemiology of resistance to antimalarial drugs in the Greater Mekong subregion: an observational study Mallika Imwong, Mehul Dhorda, Kyaw Myo Tun, The Lancet Infectious Diseases	2020	175
The impact of targeted malaria elimination with mass drug administrations on falciparum malaria in Southeast Asia: A cluster randomised trial Lorenz von Seidlein, Thomas J. Peto, Jordi Landier, PLoS Medicine	2019	164
Investigating the Efficacy of Triple Artemisinin-Based Combination Therapies for Treating Plasmodium falciparum Malaria Patients Using Mathematical Modeling S Dini, Sophie Zaloumis, Pengxing Cao, Antimicrobial Agents and Chemotherapy	2018	70
Artemisinin resistance in the malaria parasite, Plasmodium falciparum, originates from its initial transcriptional response Lei Zhu, Rob W. van der Pluijm, Michal Kucharski, Communications Biology	2022	69
A comprehensive RNA handling and transcriptomics guide for high-throughput processing of Plasmodium blood-stage samples Michal Kucharski, Jaishree Tripathi, Sourav Nayak, Malaria Journal	2020	64
Safety, Pharmacokinetics, and Mosquito‐Lethal Effects of Ivermectin in Combination With Dihydroartemisinin‐Piperaquine and Primaquine in Healthy Adult Thai Subjects Kevin C. Kobylinski, Podjanee Jittamala, Borimas Hanboonkunupakarn, Clinical Pharmacology & Therapeutics Mosquito‐lethal EffectsMalaria EliminationAntiparasitic AgentMalariaPharmacology	2019	60

Page 1